Pinheiro A, Torrecilhas A, Souza B, Cruz F, de Matos Guedes H, Ramos T
J Extracell Vesicles. 2024; 13(8):e12496.
PMID: 39113589
PMC: 11306921.
DOI: 10.1002/jev2.12496.
Fernandez-Becerra C, Xander P, Alfandari D, Dong G, Aparici-Herraiz I, Rosenhek-Goldian I
J Extracell Biol. 2024; 2(10):e117.
PMID: 38939734
PMC: 11080789.
DOI: 10.1002/jex2.117.
Vazquez M, Zabala B, Mesias A, Biscari L, Kaufman C, Alloatti A
Vaccines (Basel). 2024; 12(6).
PMID: 38932350
PMC: 11209121.
DOI: 10.3390/vaccines12060621.
Abal M, Balouz V, Lopez R, Giorgi M, Marino C, Cruz C
PLoS Negl Trop Dis. 2024; 18(1):e0011910.
PMID: 38236916
PMC: 10826959.
DOI: 10.1371/journal.pntd.0011910.
Diaz-Viraque F, Chiribao M, Libisch M, Robello C
Nat Microbiol. 2023; 8(11):2103-2114.
PMID: 37828247
PMC: 10627812.
DOI: 10.1038/s41564-023-01483-y.
(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments.
Muller G, Muller T
Biomolecules. 2023; 13(5).
PMID: 37238725
PMC: 10216265.
DOI: 10.3390/biom13050855.
Role of a 49 kDa Mucin-Associated Surface Protein (MASP49) during the Infection Process and Identification of a Mammalian Cell Surface Receptor.
Espinoza B, Martinez I, Martinez-Velasco M, Rodriguez-Sosa M, Gonzalez-Canto A, Vazquez-Mendoza A
Pathogens. 2023; 12(1).
PMID: 36678452
PMC: 9865002.
DOI: 10.3390/pathogens12010105.
Modulation of Virulence Factors during Differentiation.
Oliveira C, Holetz F, Alves L, Avila A
Pathogens. 2023; 12(1).
PMID: 36678380
PMC: 9865030.
DOI: 10.3390/pathogens12010032.
Brazilian immunology in Caxambu: beyond vaccination, a tribute to the pioneers of basic research in Chagas disease.
Scharfstein J
Mem Inst Oswaldo Cruz. 2022; 117:e210314chgsb.
PMID: 35544861
PMC: 9088418.
DOI: 10.1590/0074-02760210314chgsb.
New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.
Alonso-Vega C, Urbina J, Sanz S, Pinazo M, Pinto J, Gonzalez V
BMJ Open. 2022; 11(12):e052897.
PMID: 34972765
PMC: 8720984.
DOI: 10.1136/bmjopen-2021-052897.
All Roads Lead to Cytosol: Multi-Strategic Approach to Invasion.
Ferri G, Edreira M
Front Cell Infect Microbiol. 2021; 11:634793.
PMID: 33747982
PMC: 7973469.
DOI: 10.3389/fcimb.2021.634793.
Deletion of a Golgi protein in Trypanosoma cruzi reveals a critical role for Mn2+ in protein glycosylation needed for host cell invasion and intracellular replication.
Ramakrishnan S, Unger L, Baptista R, Cruz-Bustos T, Docampo R
PLoS Pathog. 2021; 17(3):e1009399.
PMID: 33720977
PMC: 7993795.
DOI: 10.1371/journal.ppat.1009399.
Extracellular Vesicles in Trypanosomatids: Host Cell Communication.
Torrecilhas A, Pedro Soares R, Schenkman S, Fernandez-Prada C, Olivier M
Front Cell Infect Microbiol. 2020; 10:602502.
PMID: 33381465
PMC: 7767885.
DOI: 10.3389/fcimb.2020.602502.
Genome: Organization, Multi-Gene Families, Transcription, and Biological Implications.
Herreros-Cabello A, Callejas-Hernandez F, Girones N, Fresno M
Genes (Basel). 2020; 11(10).
PMID: 33066599
PMC: 7602482.
DOI: 10.3390/genes11101196.
The Glycan Structure of mucins Depends on the Host. Insights on the Chameleonic Galactose.
Giorgi M, de Lederkremer R
Molecules. 2020; 25(17).
PMID: 32867240
PMC: 7504415.
DOI: 10.3390/molecules25173913.
Host-parasite dynamics in Chagas disease from systemic to hyper-local scales.
Perez-Mazliah D, Ward A, Lewis M
Parasite Immunol. 2020; 43(2):e12786.
PMID: 32799361
PMC: 11475410.
DOI: 10.1111/pim.12786.
Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
Campetella O, Buscaglia C, Mucci J, Leguizamon M
Biochim Biophys Acta Mol Basis Dis. 2020; 1866(5):165692.
PMID: 31972227
PMC: 7819670.
DOI: 10.1016/j.bbadis.2020.165692.
Immunity and vaccine development efforts against Trypanosoma cruzi.
Rios L, Vazquez-Chagoyan J, Pacheco A, Zago M, Garg N
Acta Trop. 2019; 200:105168.
PMID: 31513763
PMC: 7409534.
DOI: 10.1016/j.actatropica.2019.105168.
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease.
Portillo S, Zepeda B, Iniguez E, Olivas J, Karimi N, Moreira O
NPJ Vaccines. 2019; 4:13.
PMID: 30911415
PMC: 6430786.
DOI: 10.1038/s41541-019-0107-7.
Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.
Lobo M, Balouz V, Melli L, Carlevaro G, Cortina M, Camara M
PLoS Negl Trop Dis. 2019; 13(3):e0007245.
PMID: 30870417
PMC: 6435186.
DOI: 10.1371/journal.pntd.0007245.